Publication date: January 2027 Source: Neurotherapeutics, Volume 24, Issue 1 Author(s): Jun Yoshida, Rezwanul Islam, Hadi Hasan Choudhary, Tudor G. Jovin, Khalid A. Hanafy
Reperfusion enhances Treg-mediated neuroprotection and IL-10 signaling in a mouse model of large vessel occlusion. // Neurotherapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S1878747926002801?dgcid=rss_sd_all
Reperfusion enhances Treg-mediated neuroprotection and IL-10 signaling in a mouse model of large vessel occlusion. Neurotherapeutics. https://www.sciencedirect.com/science/article/pii/S1878747926002801?dgcid=rss_sd_all
“Reperfusion enhances Treg-mediated neuroprotection and IL-10 signaling in a mouse model of large vessel occlusion.” Neurotherapeutics.
@article{article60185,
title = {Reperfusion enhances Treg-mediated neuroprotection and IL-10 signaling in a mouse model of large vessel occlusion},
journal = {Neurotherapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S1878747926002801?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...